-
BMS-345541: IKK-1/IKK-2 Inhibitor Workflows
2026-09-11
Build cleaner NF-κB experiments with BMS-345541, from cytokine profiling in THP-1 cells to pathway dissection in angiogenesis and cancer models. This workflow-focused guide covers dose selection, orthogonal readouts, formulation, and troubleshooting for inflammation research and apoptosis studies.
-
Dihydroethidium (DHE) for Live-Cell Superoxide Assays
2026-09-11
Build a practical Dihydroethidium workflow for relative superoxide monitoring in live cells, with assay choices tailored to mitochondrial injury models. This guide connects DHE imaging to the irisin–renal ischemia–reperfusion study and emphasizes controls, normalization, and troubleshooting rather than fluorescence alone.
-
WEHI-539: Mapping BCL-XL-Dependent Apoptosis
2026-09-10
WEHI-539 is a selective BCL-XL inhibitor for dissecting mitochondrial apoptosis, resistance, and cancer stem cell survival. This article presents an assay-centered framework that connects BCL-XL dependency with MCL-1 compensation and experimental design.
-
PDHA1 Succinylation in Cholangiocarcinoma Therapy
2026-09-10
The reference study identifies PDHA1 K83 succinylation as a metabolic–immune link in cholangiocarcinoma, connecting altered tricarboxylic acid cycle activity and α-ketoglutaric acid accumulation with impaired macrophage antigen presentation. Its findings suggest that inhibiting this pathway with CPI-613 can improve the response to gemcitabine plus cisplatin, although validation across patient-derived models and clinical studies remains necessary.
-
High-Throughput BBB Model with Lysosomal Correction
2026-09-09
Hu and colleagues developed a Transwell surrogate blood-brain barrier model using LLC-PK1-MOCK/MDR1 cells to combine passive permeability assessment with P-glycoprotein efflux measurement. By correcting lysosomal trapping with Bafilomycin A1, the platform improved interpretation of low-recovery compounds and showed useful agreement between in vitro permeability and in vivo unbound brain distribution.
-
5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
2026-09-09
Build reproducible α2-adrenergic receptor signaling experiments with a DMSO-soluble agonist suited to receptor pharmacology, immune microenvironment studies, and post-surgical osteosarcoma recurrence models. The workflow emphasizes vehicle controls, hydrogel formulation, immune-competent comparisons, and troubleshooting of precipitation, cytotoxicity, and stability.
-
Caspase-3 Fluorometric Assay Kit for Ferroptosis
2026-09-08
Use the Caspase-3 Fluorometric Assay Kit to quantify DEVD-dependent executioner-caspase activity while dissecting apoptosis–ferroptosis crosstalk. This workflow pairs a rapid fluorescence readout with PARP1, ROS, and cell-death controls to distinguish caspase activation from broader loss of viability.
-
BI 2536: Selective PLK1 Inhibitor Guide
2026-09-08
BI 2536 is a potent ATP-competitive PLK1 inhibitor with an approximate biochemical IC50 of 0.83 nM. It supports cancer research by producing G2/M arrest, apoptosis, and antitumor responses in cellular and tumor xenograft models.
-
Cepharanthine: A Translational Assay Framework
2026-09-07
Cepharanthine is a biscoclaurine alkaloid with a growing preclinical rationale in endometriosis research. This article presents a model-selection, mechanism-validation, and compound-handling framework that separates robust assay signals from claims requiring further translation.
-
Mycophenolic Acid: Reading Metabolic Immune Assays
2026-09-07
Mycophenolic acid is a powerful dehydrogenase inhibitor for dissecting how nucleotide metabolism shapes immune-cell function. This guide moves beyond routine protocol description to show how whole-blood assay design, controls, and endpoint selection determine whether a cytokine change reflects metabolic action, cellular composition, or toxicity.
-
Chicken GSDME Drives RNA Virus-Induced Pyroptosis
2026-09-05
The reference study identifies chicken GSDME as a major pore-forming effector of pyroptosis after infection with IBDV and several other RNA viruses. Its combination of MDA5 pathway analysis, caspase-dependent cleavage mapping, and genetic loss-of-function experiments provides a mechanistic framework for studying avian antiviral cell death.
-
Bufalin Workflows for Cancer Research
2026-09-04
Bufalin is a cardiotonic steroid that supports practical studies of apoptosis, differentiation, target engagement, and protein degradation. This guide translates STK33-focused triple-negative breast cancer research into reproducible cell, binding, and organoid workflows while highlighting formulation, assay, and interpretation safeguards.
-
CTDNEP1–NEP1R1 Control ER Lipid Balance
2026-09-04
This study shows that the ER phosphatase CTDNEP1 depends on NEP1R1 for stability and for limiting ER membrane expansion, but not for restricting lipid droplet formation. By combining structure–function analysis, cellular perturbations, imaging, modeling, and biochemical assays, the authors reveal that CTDNEP1 regulation is tuned to the distinct demands of membrane synthesis and lipid storage.
-
Belinostat (PXD101): From Chromatin to Translation
2026-09-03
Belinostat (PXD101) is more than a pan-HDAC inhibitor: it is a strategic tool for connecting histone acetylation, cell-cycle arrest, tumor-cell response kinetics, and translational assay design. This article outlines how to use the compound rigorously in bladder and prostate cancer research.
-
Platycodin D Targets RFC4 in NSCLC
2026-09-03
This Molecular & Cellular Proteomics study combines thermal proteome profiling, peptide-centric stability mapping, cellular target engagement, and ubiquitinomic analysis to identify RFC4 as a functional target of platycodin D in non-small cell lung cancer. The work connects PD–RFC4 binding with impaired Notch1 and Notch3 signaling, providing a mechanistic explanation for apoptosis while also defining important limits for translating proteomic target discovery into therapeutic conclusions.